LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 3.66 | 27.76 | 677 | 283 | 2.3844 | 1.5914 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 5.36 | 27.76 | 591 | 320 | 1.8448 | 1.3790 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 5.36 | 27.76 | 760 | 320 | 2.3724 | 1.5548 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.06 | 27.76 | 659 | 360 | 1.8306 | 1.3554 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.06 | 27.76 | 6 | 360 | 0.0167 | -0.3392 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 7.06 | 27.76 | 875 | 360 | 2.4306 | 1.5431 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.76 | 27.76 | 724 | 401 | 1.8048 | 1.3312 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.76 | 27.76 | 7 | 401 | 0.0175 | -0.3006 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 8.76 | 27.76 | 930 | 401 | 2.3184 | 1.4877 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.46 | 27.76 | 777 | 438 | 1.7714 | 1.3088 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.46 | 27.76 | 8 | 438 | 0.0182 | -0.2683 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.46 | 27.76 | 1018 | 438 | 2.3208 | 1.4709 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.17 | 27.76 | 4 | 489 | 0.0082 | -0.3738 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.17 | 27.76 | 808 | 489 | 1.6521 | 1.2579 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.17 | 27.76 | 19 | 489 | 0.0388 | -0.0875 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 12.17 | 27.76 | 1069 | 489 | 2.1858 | 1.4159 | MN20160318_Q01 | L17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 13.87 | 27.76 | 2 | 604 | 0.0033 | -0.4466 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 13.87 | 27.76 | 840 | 604 | 1.3891 | 1.1535 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 13.87 | 27.76 | 23 | 604 | 0.0380 | -0.0414 | MN20160318_Q01 | L17 |